Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

CCR8 is expressed by post-positive selection CD4-lineage thymocytes but is dispensable for central tolerance induction.

Tytuł:
CCR8 is expressed by post-positive selection CD4-lineage thymocytes but is dispensable for central tolerance induction.
Autorzy:
Thyagarajan HM; Department of Molecular Biosciences, Institute for Cellular and Molecular Biology, The University of Texas at Austin, Austin, Texas, United States of America.
Lancaster JN; Department of Molecular Biosciences, Institute for Cellular and Molecular Biology, The University of Texas at Austin, Austin, Texas, United States of America.
Lira SA; Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Ehrlich LIR; Department of Molecular Biosciences, Institute for Cellular and Molecular Biology, The University of Texas at Austin, Austin, Texas, United States of America.; Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin, Austin, Texas, United States of America.
Źródło:
PloS one [PLoS One] 2018 Jul 19; Vol. 13 (7), pp. e0200765. Date of Electronic Publication: 2018 Jul 19 (Print Publication: 2018).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Original Publication: San Francisco, CA : Public Library of Science
MeSH Terms:
CD4 Antigens/*metabolism
Receptors, CCR8/*metabolism
Thymocytes/*metabolism
Animals ; Antigen-Presenting Cells/metabolism ; Flow Cytometry ; Fluorescent Antibody Technique ; Mice ; Mice, Inbred C57BL ; Receptors, CCR7/genetics ; Receptors, CCR7/metabolism ; Receptors, CCR8/genetics
References:
Eur J Immunol. 2017 Nov;47(11):1906-1917. (PMID: 28741728)
Immunol Cell Biol. 1998 Feb;76(1):34-40. (PMID: 9553774)
Annu Rev Immunol. 2007;25:649-79. (PMID: 17291187)
Immunity. 2008 Sep 19;29(3):438-50. (PMID: 18799150)
J Immunol. 2011 Feb 1;186(3):1421-31. (PMID: 21178002)
Cell Rep. 2014 Oct 9;9(1):402-415. (PMID: 25284794)
J Exp Med. 2004 Aug 16;200(4):493-505. (PMID: 15302902)
J Immunol. 2003 Nov 1;171(9):4521-7. (PMID: 14568925)
Trends Immunol. 2018 Feb;39(2):86-98. (PMID: 29162323)
Blood. 2011 Sep 1;118(9):2462-72. (PMID: 21505196)
Semin Immunol. 2005 Aug;17(4):304-12. (PMID: 15946853)
Nat Rev Immunol. 2011 Jun 24;11(7):469-77. (PMID: 21701522)
Methods Mol Biol. 2017;1591:9-25. (PMID: 28349472)
Blood. 2010 Mar 11;115(10):1906-12. (PMID: 20040757)
J Exp Med. 2017 Jul 3;214(7):1925-1935. (PMID: 28611158)
J Immunol. 2009 Dec 15;183(12):7909-18. (PMID: 19933868)
Nat Immunol. 2010 Feb;11(2):162-70. (PMID: 20010845)
Nat Immunol. 2016 May;17(5):565-73. (PMID: 27043411)
Nat Rev Immunol. 2014 Jun;14(6):377-91. (PMID: 24830344)
PLoS One. 2012;7(1):e30793. (PMID: 22292042)
Immunity. 2008 Sep 19;29(3):451-63. (PMID: 18799151)
PLoS One. 2012;7(7):e40321. (PMID: 22815738)
Immunity. 2006 Feb;24(2):165-77. (PMID: 16473829)
J Immunol. 2014 Aug 1;193(3):1204-12. (PMID: 24990081)
J Immunol. 2006 Nov 15;177(10):6940-51. (PMID: 17082609)
J Immunol. 2001 Jan 1;166(1):218-25. (PMID: 11123295)
Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):17129-33. (PMID: 19805112)
J Clin Invest. 2001 Jun;107(11):1357-64. (PMID: 11390417)
Int Immunol. 2015 Apr;27(4):169-81. (PMID: 25344933)
Proc Natl Acad Sci U S A. 2017 Jun 6;114(23):6086-6091. (PMID: 28533380)
Nat Immunol. 2011 Feb;12(2):167-77. (PMID: 21217759)
Nat Immunol. 2006 Oct;7(10):1092-100. (PMID: 16951687)
Cell Rep. 2017 Oct 3;21(1):168-180. (PMID: 28978470)
Blood. 2013 Aug 1;122(5):825-36. (PMID: 23798714)
Immunity. 2013 Jun 27;38(6):1116-28. (PMID: 23746651)
J Exp Med. 1998 Jul 20;188(2):409-14. (PMID: 9670054)
J Immunol. 1996 Sep 15;157(6):2570-6. (PMID: 8805659)
Blood. 2010 Mar 11;115(10):1897-905. (PMID: 19965655)
J Exp Med. 2001 Mar 5;193(5):573-84. (PMID: 11238588)
J Exp Med. 2006 Nov 27;203(12):2727-35. (PMID: 17116738)
J Exp Med. 2015 Oct 19;212(11):1947-65. (PMID: 26417005)
J Leukoc Biol. 2003 Jan;73(1):201-7. (PMID: 12525579)
Nat Immunol. 2015 Sep;16(9):933-41. (PMID: 26237553)
J Immunol. 1998 Jul 15;161(2):547-51. (PMID: 9670926)
Annu Rev Immunol. 2012;30:531-64. (PMID: 22224781)
Genome Res. 2014 Dec;24(12):1918-31. (PMID: 25224068)
Immunity. 2009 Dec 18;31(6):986-98. (PMID: 19962328)
Immunity. 2008 Sep 19;29(3):423-37. (PMID: 18799149)
Nat Immunol. 2015 Sep;16(9):942-9. (PMID: 26237550)
Grant Information:
R01 AI104870 United States AI NIAID NIH HHS; R01 DK110352 United States DK NIDDK NIH HHS
Substance Nomenclature:
0 (CD4 Antigens)
0 (Ccr7 protein, mouse)
0 (Ccr8 protein, mouse)
0 (Receptors, CCR7)
0 (Receptors, CCR8)
Entry Date(s):
Date Created: 20180720 Date Completed: 20190122 Latest Revision: 20220510
Update Code:
20240105
PubMed Central ID:
PMC6053179
DOI:
10.1371/journal.pone.0200765
PMID:
30024927
Czasopismo naukowe
Following positive selection, thymocytes migrate into the medulla where they encounter diverse self-antigens that induce central tolerance. Thymocytes expressing T cell receptors (TCRs) with high affinity for self-antigens displayed by medullary antigen presenting cells (APCs) undergo either negative selection or diversion to the regulatory T cell (Treg) lineage, thus ensuring maturation of non-autoreactive T cells. Because many self-antigens are expressed by only a small percentage of medullary thymic epithelial cells, thymocytes must enter the medulla and efficiently scan APCs therein to encounter the full array of self-antigens that induce central tolerance. Chemokine receptors play a critical role in promoting medullary entry and rapid motility of post-positive selection thymocytes. We found that the chemokine receptor CCR8 is expressed by post-positive selection CD4+ single positive (SP) thymocytes in mice, while the corresponding chemokine ligands are expressed by medullary APCs, and thus hypothesized that CCR8 would promote thymocyte medullary entry and/or rapid motility to induce negative selection. However, despite a subtle decline in thymocyte medullary accumulation and the presence of autoantibodies in aged CCR8-deficient mice, CCR8 was not required for thymocyte differentiation, rapid motility, or negative selection.
Competing Interests: The authors have declared that no competing interests exist.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies